SEARCH RESULTS FOR: "Tag: BLUE"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2020(1)
2019(3)
2018(5)
2017(12)
2016(11)
2015(21)
2014(2)
CATEGORIES
5-Minute Market Rundown(1)
Analyst Downgrades(2)
Analyst Update(11)
Analyst Upgrades(4)
Buzz Stocks(7)
Ezines(1)
General(7)
Intraday Option Activity(3)
Market Recap(1)
Midday Market Check(6)
Opening View(3)
Stock Market News(4)
Stocks On the Move(11)
Trade Postmortem(1)
Unusual Trading Activity(2)

2/19/2020 1:53 PM
Gene therapy developer bluebird bio Inc (NASDAQ:BLUE) is down 9% at $80.64 in afternoon trading, sinking after weak fourth-quarter results and news its blood disorder therapy drug Zynteglo applicatio...
12/10/2019 12:03 PM
It's another day of weak price action for stocks on Wall Street, with traders mostly holding tight ahead of tomorrow's Fed decision. Ahead of the opening bell, it looked as though apparent headway i...
11/4/2019 2:42 PM
The U.S. stock market is soaring once more, with all three benchmarks nabbing new record highs. Among specific stocks making notable moves higher are gene therapy specialist bluebird bio Inc (NASDAQ...
9/27/2019 9:17 AM
Futures on the Dow Jones Industrial Average (DJI) are above fair value this morning, after the U.S. and China said they will hold two-day high-level trade negotiations beginning on Thursday, Oct. 1...
8/6/2018 9:16 AM
Massachusetts-based biotech company bluebird bio (NASDAQ:BLUE) today announced a collaboration with Regeneron Pharmaceuticals (NASDAQ:REGN) to jointly develop new cell therapies for cancer. Under the...